Mitogenic conversion of transforming growth factor-β1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer

Bum Joon Park, Jae I. Park, Do S. Byun, Jae Hoon Park, Sung-Gil Chi

Research output: Contribution to journalArticle

94 Citations (Scopus)

Abstract

Elevated expression of transforming growth factor (TGF)-β1 has been implicated in prostate tumorigenesis despite its growth-inhibitory effect on normal epithelial and carcinoma cells of the prostate. In this study, we identified that G1-to-S transition of the cell cycle is stimulated by TGF- β1 in the prostate cancer cell line TSU-Pr1. No mutation of signal mediators, including Smads, and induction of PAI-1 transcription indicated that the TGF-β1 signaling cascade is functionally intact in this cell line. Whereas pharmacological inhibitors of various mitogenic signaling pathways showed no effects, blockade of the mitogen-activated protein kinase (MAPK) pathway by the MAPK kinase 1 inhibitor PD98059 restored the growth inhibitory role of TGF-β1 in TSU-Pr1, which carries an oncogenic mutation in Ha-Ras (V12). Moreover, expression of antisense Ha-Ras or dominant negative Raf-1 abrogated the mitogenic effect of TGF-β1 in TSU-Pr1, and the TGF-β1 inhibition of DU145 was switched to stimulation by V12Ha-Ras transfection. Whereas the negative growth regulation by TGF-β1 was completely inhibited by dominant negative Smad2, Smad3, or Smad4, its mitogenic effect was not affected, suggesting that this action is Smad-independent. Interestingly, whereas the TGF-β1-mediated up-regulation of p15(INK4B) and p21(WAF1) transcription was abolished in TSU-Pr1 and V12Ha-Ras-transfected DU145, inhibition of the Ras/MAPK pathway restored the TGF-β1 induction of these genes. Taken together, our data suggest that prostate carcinomas with the Ras/MAPK pathway activation might have a selective growth advantage by autocrine TGF-β1 production.

Original languageEnglish
Pages (from-to)3031-3038
Number of pages8
JournalCancer Research
Volume60
Issue number11
Publication statusPublished - 2000 Jun 1
Externally publishedYes

Fingerprint

Transforming Growth Factors
Mitogen-Activated Protein Kinases
Prostatic Neoplasms
Prostate
Growth
MAP Kinase Kinase Kinase 1
Carcinoma
Cell Line
Mutation
Plasminogen Activator Inhibitor 1
Transfection
Cell Cycle
Carcinogenesis
Up-Regulation
Epithelial Cells
Pharmacology

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Mitogenic conversion of transforming growth factor-β1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer. / Park, Bum Joon; Park, Jae I.; Byun, Do S.; Park, Jae Hoon; Chi, Sung-Gil.

In: Cancer Research, Vol. 60, No. 11, 01.06.2000, p. 3031-3038.

Research output: Contribution to journalArticle

@article{e976445b7d8041dd803ff7da1f227cb5,
title = "Mitogenic conversion of transforming growth factor-β1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer",
abstract = "Elevated expression of transforming growth factor (TGF)-β1 has been implicated in prostate tumorigenesis despite its growth-inhibitory effect on normal epithelial and carcinoma cells of the prostate. In this study, we identified that G1-to-S transition of the cell cycle is stimulated by TGF- β1 in the prostate cancer cell line TSU-Pr1. No mutation of signal mediators, including Smads, and induction of PAI-1 transcription indicated that the TGF-β1 signaling cascade is functionally intact in this cell line. Whereas pharmacological inhibitors of various mitogenic signaling pathways showed no effects, blockade of the mitogen-activated protein kinase (MAPK) pathway by the MAPK kinase 1 inhibitor PD98059 restored the growth inhibitory role of TGF-β1 in TSU-Pr1, which carries an oncogenic mutation in Ha-Ras (V12). Moreover, expression of antisense Ha-Ras or dominant negative Raf-1 abrogated the mitogenic effect of TGF-β1 in TSU-Pr1, and the TGF-β1 inhibition of DU145 was switched to stimulation by V12Ha-Ras transfection. Whereas the negative growth regulation by TGF-β1 was completely inhibited by dominant negative Smad2, Smad3, or Smad4, its mitogenic effect was not affected, suggesting that this action is Smad-independent. Interestingly, whereas the TGF-β1-mediated up-regulation of p15(INK4B) and p21(WAF1) transcription was abolished in TSU-Pr1 and V12Ha-Ras-transfected DU145, inhibition of the Ras/MAPK pathway restored the TGF-β1 induction of these genes. Taken together, our data suggest that prostate carcinomas with the Ras/MAPK pathway activation might have a selective growth advantage by autocrine TGF-β1 production.",
author = "Park, {Bum Joon} and Park, {Jae I.} and Byun, {Do S.} and Park, {Jae Hoon} and Sung-Gil Chi",
year = "2000",
month = "6",
day = "1",
language = "English",
volume = "60",
pages = "3031--3038",
journal = "Cancer Research",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

TY - JOUR

T1 - Mitogenic conversion of transforming growth factor-β1 effect by oncogenic Ha-Ras-induced activation of the mitogen-activated protein kinase signaling pathway in human prostate cancer

AU - Park, Bum Joon

AU - Park, Jae I.

AU - Byun, Do S.

AU - Park, Jae Hoon

AU - Chi, Sung-Gil

PY - 2000/6/1

Y1 - 2000/6/1

N2 - Elevated expression of transforming growth factor (TGF)-β1 has been implicated in prostate tumorigenesis despite its growth-inhibitory effect on normal epithelial and carcinoma cells of the prostate. In this study, we identified that G1-to-S transition of the cell cycle is stimulated by TGF- β1 in the prostate cancer cell line TSU-Pr1. No mutation of signal mediators, including Smads, and induction of PAI-1 transcription indicated that the TGF-β1 signaling cascade is functionally intact in this cell line. Whereas pharmacological inhibitors of various mitogenic signaling pathways showed no effects, blockade of the mitogen-activated protein kinase (MAPK) pathway by the MAPK kinase 1 inhibitor PD98059 restored the growth inhibitory role of TGF-β1 in TSU-Pr1, which carries an oncogenic mutation in Ha-Ras (V12). Moreover, expression of antisense Ha-Ras or dominant negative Raf-1 abrogated the mitogenic effect of TGF-β1 in TSU-Pr1, and the TGF-β1 inhibition of DU145 was switched to stimulation by V12Ha-Ras transfection. Whereas the negative growth regulation by TGF-β1 was completely inhibited by dominant negative Smad2, Smad3, or Smad4, its mitogenic effect was not affected, suggesting that this action is Smad-independent. Interestingly, whereas the TGF-β1-mediated up-regulation of p15(INK4B) and p21(WAF1) transcription was abolished in TSU-Pr1 and V12Ha-Ras-transfected DU145, inhibition of the Ras/MAPK pathway restored the TGF-β1 induction of these genes. Taken together, our data suggest that prostate carcinomas with the Ras/MAPK pathway activation might have a selective growth advantage by autocrine TGF-β1 production.

AB - Elevated expression of transforming growth factor (TGF)-β1 has been implicated in prostate tumorigenesis despite its growth-inhibitory effect on normal epithelial and carcinoma cells of the prostate. In this study, we identified that G1-to-S transition of the cell cycle is stimulated by TGF- β1 in the prostate cancer cell line TSU-Pr1. No mutation of signal mediators, including Smads, and induction of PAI-1 transcription indicated that the TGF-β1 signaling cascade is functionally intact in this cell line. Whereas pharmacological inhibitors of various mitogenic signaling pathways showed no effects, blockade of the mitogen-activated protein kinase (MAPK) pathway by the MAPK kinase 1 inhibitor PD98059 restored the growth inhibitory role of TGF-β1 in TSU-Pr1, which carries an oncogenic mutation in Ha-Ras (V12). Moreover, expression of antisense Ha-Ras or dominant negative Raf-1 abrogated the mitogenic effect of TGF-β1 in TSU-Pr1, and the TGF-β1 inhibition of DU145 was switched to stimulation by V12Ha-Ras transfection. Whereas the negative growth regulation by TGF-β1 was completely inhibited by dominant negative Smad2, Smad3, or Smad4, its mitogenic effect was not affected, suggesting that this action is Smad-independent. Interestingly, whereas the TGF-β1-mediated up-regulation of p15(INK4B) and p21(WAF1) transcription was abolished in TSU-Pr1 and V12Ha-Ras-transfected DU145, inhibition of the Ras/MAPK pathway restored the TGF-β1 induction of these genes. Taken together, our data suggest that prostate carcinomas with the Ras/MAPK pathway activation might have a selective growth advantage by autocrine TGF-β1 production.

UR - http://www.scopus.com/inward/record.url?scp=0034214211&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034214211&partnerID=8YFLogxK

M3 - Article

VL - 60

SP - 3031

EP - 3038

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 11

ER -